Hepatocellular Carcinoma with Segmental Portal Vein Invasion Exhibiting a Complete Response after Transarterial Radioembolization
Journal of Liver Cancer
;
: 159-164, 2019.
Artículo
en Inglés
| WPRIM
| ID: wpr-765712
ABSTRACT
The treatment options available for patients with hepatocellular carcinoma (HCC) with portal vein invasion (PVI) include sorafenib, transarterial radioembolization (TARE), radiation therapy (RT), transarterial chemoembolization with RT, and proton beam irradiation. Herein, we present a case of HCC with segmental PVI that was managed via TARE. The patient had a 4 cm HCC that invaded the segment VIII portal vein branch without extrahepatic spread. Liver function was Child-Pugh grade A, and performance status was good. TARE was performed without any adverse events, and a radiological complete response (CR) was achieved. Thereafter, the patient was followed-up every 3–6 months without any further treatment, and the CR was maintained for >3 years. Therefore, TARE may be a useful alternative therapeutic option for patients with HCC exhibiting segmental PVI.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Vena Porta
/
Protones
/
Radioterapia
/
Carcinoma Hepatocelular
/
Trombosis de la Vena
/
Embolización Terapéutica
/
Hígado
Límite:
Humanos
Idioma:
Inglés
Revista:
Journal of Liver Cancer
Año:
2019
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS